INS and type 1 diabetes mellitus: Even though such newly generated β-cells would be subject to immune rejection, our data could imply a temporary net gain in β-cells at disease onset which might explain or contribute to the reduced insulin requirements patients typically experience shortly after T1DM diagnosis, commonly known as “honeymoon” [13].